Award
Delivery Order #SPE2D326F6298
Short-Term Delivery Order for Ketorolac Vials to DoD by Fresenius Kabi
Buyer
Defense Logistics Agency
Award Amount
$213.14
Ceiling
$213.14
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2D326F6298
NAICS
325411
This award represents a delivery order contract issued under an existing indefinite delivery vehicle with Fresenius Kabi, LLC, a leading pharmaceutical manufacturer specializing in critical medical supplies. The contract involves the procurement of ketorolac 30 mg/ml vials, a nonsteroidal anti-inflammatory drug vital for pain management in military medical settings. This short-term contract supports the U.S. Department of Defense's ongoing efforts to maintain medical readiness by ensuring timely availability of essential pharmaceuticals. The scope includes the supply and delivery of the specific medication to a designated location in Lake Zurich, Illinois, within a concise three-day performance window. This delivery order is part of a competitive, long-term framework contract established to provide a reliable source of medical products to the military. No key subcontractors or additional acquisition programs are associated with this order. The contract is linked to a substantial multi-year agreement awarded previously, reflecting continuity in securing dependable medical supplies for defense health services.
Description
4570915132!KETOROLAC 30 MG/ML VIALML